Sensitivity of cross-reacting antihuman antibodies in formalin-fixed porcine skin: including antibodies to proliferation antigens and cytokeratins with specificity in the skin. 1998

K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
Medical Research Institute of Chemical Defense, Aberdeen, MD, USA.

Although no animal is a perfect skin model for the study of toxicological and therapeutic agents, structurally the pig may be superior to even non-human primates. Because our work involves effects of toxicological and therapeutic agents on the skin, we wanted to identify stains which may prove useful as well as determine cross-reactivity of some newer antihuman antibodies. We performed a battery of formalin-fixed skin from weanling pigs and minipigs. The battery of antibodies included LCA, CD3, OPD-4, CD34, UCHL-1, L-26, KP-1, MAC-387, Factor XIIIa, Leu-7, S-100 protein, HMB-45, GFAP, synaptophysin, neurofilament protein, ubiquitin, vimentin, type IV collagen, laminin, fibronectin, Factor VIII related antigen, Desmin-M, smooth muscle actin, cytokeratin 7, cytokeratin 20, AEI/AE3, CAM 5.2, EMA, GCDFP, Ki-67, and PCNA. Immunohistochemical stains for CD3, Leu-7, S-100 protein, type IV collagen, laminin, Factor VIII related antigen, GFAP, synaptophysin, neurofilament protein, ubiquitin, smooth muscle actin, vimentin, Desmin-M, cytokeratin 7, cytokeratin 20, AE1/AE3, CAM 5.2, Ki-67 and PCNA showed consistent cross-reactivity. In formalin-fixed tissue, only antibodies to lymphoreticular cells showed poor cross-reactivity. A high percentage of the remaining antibodies did show good cross-reactivity but with some interesting similarities and differences in specificity.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007633 Keratins A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION. Cytokeratin,Keratin Associated Protein,Keratin,Keratin-Associated Proteins,alpha-Keratin,Associated Protein, Keratin,Keratin Associated Proteins,Protein, Keratin Associated,alpha Keratin
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
January 1995, Berliner und Munchener tierarztliche Wochenschrift,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
December 1971, Nature: New biology,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
February 1974, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
September 1980, Pediatric research,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
November 1984, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
January 2006, American journal of clinical pathology,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
May 1991, Biulleten' eksperimental'noi biologii i meditsiny,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
July 2003, Veterinary immunology and immunopathology,
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
July 1964, Journal of immunology (Baltimore, Md. : 1950),
K J Smith, and J S Graham, and H G Skelton, and T Hamilton, and T O'Leary, and C V Okerberg, and R Moeller, and C G Hurst
February 1993, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!